Clinical trial
Judging the Efficacy of Secukinumab in Patients With Psoriasis Using AutoiNjector: a Clinical Trial Evaluating Treatment Results (JUNCTURE) (JUNCTURE)
The purpose of this study is to demonstrate efficacy of autoinjector administered secukinumab at Week 12 based on PASI and IGA response rates versus placebo in subjects with moderate to severe chronic plaque-type psoriasis.
| Category | Value |
|---|---|
| Study type(s) | Interventional |
| Expected enrolment | 182 |
| Study start date | 2012-10-01 |
| Estimated primary completion date | 2016-10-01 |